Ketan Sablok - Rossari Biotech Group Officer
| ROSSARI Stock | 822.80 5.35 0.65% |
Executive
Ketan Sablok is Group Officer of Rossari Biotech Limited
| Address | 201 A & B, Akruti Corporate Park, Mumbai, India, 400078 |
| Phone | 91 22 6123 3800 |
| Web | https://www.rossari.com |
Rossari Biotech Management Efficiency
The company has return on total asset (ROA) of 0.0735 % which means that it generated a profit of $0.0735 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1324 %, meaning that it generated $0.1324 on every $100 dollars invested by stockholders. Rossari Biotech's management efficiency ratios could be used to measure how well Rossari Biotech manages its routine affairs as well as how well it operates its assets and liabilities. As of now, Rossari Biotech's Other Current Assets are increasing as compared to previous years. The Rossari Biotech's current Intangible Assets is estimated to increase to about 1.5 B, while Total Assets are projected to decrease to under 7.9 B.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Kamaljeet Singh | Indian Card Clothing | N/A | |
| Prasad Mahale | Indian Card Clothing | 47 | |
| Gurpreet Samrao | Indian Card Clothing | N/A | |
| Sadananda BCom | Coffee Day Enterprises | 60 | |
| Radhakrishnan Mohan | Coffee Day Enterprises | 70 | |
| Rajkumar Muthukkumar | AUTHUM INVESTMENT INFRASTRUCTU | N/A | |
| Ashok Kheny | BF Utilities Limited | 74 | |
| M Bhushan | Coffee Day Enterprises | N/A | |
| Pragati Rai | BF Utilities Limited | N/A | |
| Ajay Mittal | Nalwa Sons Investments | 32 | |
| Sriram Swaminathan | Indian Card Clothing | 61 | |
| Alok BTech | Indian Card Clothing | 59 | |
| Madan Gupta | Nalwa Sons Investments | N/A | |
| S Deivakumar | Indian Card Clothing | 54 | |
| Chandrakant Patil | Indian Card Clothing | 45 | |
| Vishal MBA | Indian Card Clothing | 39 | |
| Devahuthi Gangwani | Coffee Day Enterprises | N/A | |
| Vinodhini Kanagaraj | S P Apparels | 36 | |
| Bittu Upadhyaya | AUTHUM INVESTMENT INFRASTRUCTU | N/A | |
| Deepak Dhingra | AUTHUM INVESTMENT INFRASTRUCTU | N/A | |
| Ketan Sanghvi | Coffee Day Enterprises | N/A | |
Management Performance
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0735 |
Rossari Biotech Leadership Team
Elected by the shareholders, the Rossari Biotech's board of directors comprises two types of representatives: Rossari Biotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Rossari. The board's role is to monitor Rossari Biotech's management team and ensure that shareholders' interests are well served. Rossari Biotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Rossari Biotech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Manasi Nisal, Senior Analytics | ||
| Yash Chari, Director Development | ||
| Prasad Gadkari, President Manufacturing | ||
| Sunil Chari, MD CoFounder | ||
| Sunil Nair, Chief Communications | ||
| Ketan Sablok, Group Officer | ||
| Edward Menezes, CoFounder Chairman | ||
| Mikhail Menezes, Director Technical | ||
| Shifa Suresh, Vice Administration | ||
| Parul Gupta, Company Officer | ||
| Puneet Arora, Chief Global |
Rossari Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Rossari Biotech a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0735 | ||||
| Profit Margin | 0.07 % | ||||
| Operating Margin | 0.10 % | ||||
| Current Valuation | 45.96 B | ||||
| Shares Outstanding | 55.36 M | ||||
| Shares Owned By Insiders | 68.18 % | ||||
| Shares Owned By Institutions | 19.08 % | ||||
| Price To Book | 4.05 X | ||||
| Price To Sales | 2.38 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Rossari Stock
Rossari Biotech financial ratios help investors to determine whether Rossari Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Rossari with respect to the benefits of owning Rossari Biotech security.